Form D — Centerline Biomedical, Inc.
0001998847-25-000002 · filed Apr 25, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $15,000,000
- Reported amount sold
- $10,784,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Centerline Biomedical, Inc.
- CIK
- 1998847
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 4535 Renaissance Parkway
Warrensville Heights, Ohio 44128 - Phone
- 216-445-0830
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Gulam Khan · Executive OfficerWarrensville Heights, Ohio Find on LinkedIn ↗
-
Indrani Egleston · Executive OfficerWarrensville Heights, Ohio Find on LinkedIn ↗
-
Michael Whitman · DirectorWarrensville Heights, Ohio Find on LinkedIn ↗
-
Mitch Wolf · DirectorWarrensville Heights, Ohio Find on LinkedIn ↗
-
Todd Schwarzinger · DirectorWarrensville Heights, Ohio Find on LinkedIn ↗
-
Arnaud Marie · DirectorWarrensville Heights, Ohio Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗